{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:29:17Z","timestamp":1777328957777,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Differentiating between low-grade glioma and brain glial cell hyperplasia is crucial for the customized clinical treatment of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Based on multiparametric MRI imaging and clinical risk factors, a radiomics-clinical model and nomogram were constructed for the distinction of brain glial cell hyperplasia from low-grade glioma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with brain glial cell hyperplasia and low-grade glioma who underwent surgery at the First Affiliated Hospital of Soochow University from March 2016 to March 2022 were retrospectively included. In this study, A total of 41 patients of brain glial cell hyperplasia and 87 patients of low-grade glioma were divided into training group and validation group randomly at a ratio of 7:3. Radiomics features were extracted from T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), contrast-enhanced T1-weighted imaging (T1-enhanced). Then, LASSO, SVM, and RF models were created in order to choose a model with a greater level of efficiency for calculating each patient\u2019s Rad-score (radiomics score). The independent risk factors were identified via univariate and multivariate logistic regression analysis to filter the Rad-score and clinical risk variables in turn. A radiomics-clinical model was next built of which effectiveness was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Brain glial cell hyperplasia and low-grade gliomas from the 128 cases were randomly divided into 10 groups, of which 7 served as training group and 3 as validation group. The mass effect and Rad-score were two independent risk variables used in the construction of the radiomics-clinical model, and their respective AUCs for the training group and validation group were 0.847 and 0.858. The diagnostic accuracy, sensitivity, and specificity of the validation group were 0.821, 0.750, and 0.852 respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Combining with radiomics constructed by multiparametric MRI images and clinical features, the radiomics-clinical model and nomogram that were developed to distinguish between brain glial cell hyperplasia and low-grade glioma had a good performance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12880-023-01086-3","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T04:18:32Z","timestamp":1693801112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Multiparametric MRI radiomics for the differentiation of brain glial cell hyperplasia from low-grade glioma"],"prefix":"10.1186","volume":"23","author":[{"given":"Siqian","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhilei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"issue":"2","key":"1086_CR1","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/neup.12715","volume":"41","author":"S Mori","year":"2021","unstructured":"Mori S, Suzuki SO, Honda H, Hamasaki H, Sakae N, Sasagasako N, et al. Symmetrical glial hyperplasia in the brainstem of fibrodysplasia ossificans progressiva. Neuropathology. 2021;41(2):146\u201351.","journal-title":"Neuropathology"},{"issue":"3","key":"1086_CR2","first-page":"15","volume":"7","author":"Z Shao-Feng","year":"2021","unstructured":"Shao-Feng Z, Yi-Wei H, Yang S, Si-Jie X, Jian-Ming S, Hong-Bo Y. Research based on the inflammatory response caused by the proliferation of glial cells in Alzheimer\u2019s Disease. World J Complex Med. 2021;7(3):15\u20137.","journal-title":"World J Complex Med"},{"key":"1086_CR3","doi-asserted-by":"crossref","unstructured":"Shenoy A. Clinical applications of imaging biomarkers. Part 3. The neuro-oncologist\u2019s perspective. Br J Radiol, 2011, 84 Spec No 2(Spec Iss 2): S209\u201312.","DOI":"10.1259\/bjr\/38240981"},{"issue":"5","key":"1086_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/02688697.2018.1464121","volume":"34","author":"Z Feng","year":"2020","unstructured":"Feng Z, Mao Z, Wang Z, Liao B, Zhu Y, Wang H. Non-adenomatous pituitary tumours mimicking functioning pituitary adenomas. Br J Neurosurg. 2020;34(5):487\u201391.","journal-title":"Br J Neurosurg"},{"issue":"3","key":"1086_CR5","first-page":"263","volume":"41","author":"S Biaorui","year":"2019","unstructured":"Biaorui S, Zhenyu L, Pingping H, Yu L. Effect of electroacupuncture on reactive astrogliosis of rats with spinal cord injury. Int J Traditional Chin Med. 2019;41(3):263\u20138.","journal-title":"Int J Traditional Chin Med"},{"issue":"11","key":"1086_CR6","first-page":"1445","volume":"51","author":"M Ruining","year":"2022","unstructured":"Ruining M, Huilian H, Yu L, Guanjun Z, Hongya W, Huilin G, et al. Quantitative analysis of astrocyte morphology in penumbra of cerebral infarction and it ssignificance. Shaanxi Med J. 2022;51(11):1445\u20138.","journal-title":"Shaanxi Med J"},{"issue":"11","key":"1086_CR7","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.acra.2020.06.016","volume":"28","author":"S Gore","year":"2021","unstructured":"Gore S, Chougule T, Jagtap J, Saini J, Ingalhalikar M. A review of Radiomics and Deep Predictive modeling in Glioma characterization. Acad Radiol. 2021;28(11):1599\u2013621.","journal-title":"Acad Radiol"},{"issue":"2","key":"1086_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s13311-017-0519-x","volume":"14","author":"R Chen","year":"2017","unstructured":"Chen R, Smith-Cohn M, Cohen AL, Colman H. Glioma Subclassifications and their clinical significance. Neurotherapeutics. 2017;14(2):284\u201397.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"1086_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12943-018-0812-2","volume":"17","author":"Z Peng","year":"2018","unstructured":"Peng Z, Liu C, Wu M. New insights into long noncoding RNAs and their roles in glioma. Mol Cancer. 2018;17(1):61.","journal-title":"Mol Cancer"},{"key":"1086_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1200\/EDBK_238353","volume":"39","author":"MC Tom","year":"2019","unstructured":"Tom MC, Cahill DP, Buckner JC, Dietrich J, Parsons MW, Yu JS. Management for different glioma subtypes: are all Low-Grade Gliomas created Equal? Am Soc Clin Oncol Educ Book. 2019;39:133\u201345.","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"8","key":"1086_CR11","first-page":"1243","volume":"17","author":"L Shahqu","year":"2011","unstructured":"Shahqu L, Bo Y, Zhenwei Z, Huizhong Z, Yang L. Magnetic resonance imaging of glial cell hyperplasia in patients with Brmn Gliosis. Med RECAPITULATE. 2011;17(8):1243\u20135.","journal-title":"Med RECAPITULATE"},{"issue":"3","key":"1086_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.23736\/S1824-4785.18.03086-8","volume":"62","author":"WB Pope","year":"2018","unstructured":"Pope WB, Brandal G. Conventional and advanced magnetic resonance imaging in patients with high-grade glioma. Q J Nucl Med Mol Imaging. 2018;62(3):239\u201353.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"4","key":"1086_CR13","first-page":"354","volume":"43","author":"Y Leng","year":"2018","unstructured":"Leng Y, Wang X, Liao W, Cao Y. Radiomics in gliomas: a promising assistance for glioma clinical research. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43(4):354\u20139.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"10","key":"1086_CR14","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s00066-020-01626-8","volume":"196","author":"M Kocher","year":"2020","unstructured":"Kocher M, Ruge MI, Galldiks N, Lohmann P. Applications of radiomics and machine learning for radiotherapy of malignant brain tumors. Strahlenther Onkol. 2020;196(10):856\u201367.","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"1086_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41698-021-00205-z","volume":"5","author":"J Yan","year":"2021","unstructured":"Yan J, Zhang B, Zhang S, Cheng J, Liu X, Wang W, et al. Quantitative MRI-based radiomics for noninvasively predicting molecular subtypes and survival in glioma patients. NPJ Precis Oncol. 2021;5(1):72.","journal-title":"NPJ Precis Oncol"},{"issue":"1\u20132","key":"1086_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jneuroim.2010.09.020","volume":"231","author":"A Czlonkowska","year":"2011","unstructured":"Czlonkowska A, Kurkowska-Jastrzebska I. Inflammation and gliosis in neurological diseases\u2013clinical implications. J Neuroimmunol. 2011;231(1\u20132):78\u201385.","journal-title":"J Neuroimmunol"},{"issue":"02","key":"1086_CR17","first-page":"108","volume":"1","author":"W Ying","year":"2012","unstructured":"Ying W, Xiaohua Z, Shaorong C, Zhiqiang S, Huibin T, Yousan C, et al. Routine and functional MRI of brain gliosis. Funct Mol Med Imaging (Electronic Edition). 2012;1(02):108\u201313.","journal-title":"Funct Mol Med Imaging (Electronic Edition)"},{"issue":"20","key":"1086_CR18","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.1073\/pnas.85.20.7748","volume":"85","author":"M Hermansson","year":"1988","unstructured":"Hermansson M, Nister M, Betsholtz C, Heldin CH, Westermark B, Funa K. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc Natl Acad Sci U S A. 1988;85(20):7748\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1086_CR19","first-page":"632","volume":"44","author":"YD Zhu","year":"2021","unstructured":"Zhu YD, Yu YX, Yang L. Radiomic model based on DCE-MRI for the preoperative prediction of SLN metastasis in breast cancer. Int J Med Radiol. 2021;44(6):632\u20137.","journal-title":"Int J Med Radiol"},{"key":"1086_CR20","doi-asserted-by":"crossref","unstructured":"Zhao L, Ma B. Radiomics features of different sizes of medullary thyroid carcinoma (MTC) and papillary thyroid carcinoma (PTC) tumors: a comparative study. Clin Med Insights Oncol, 2022,16(9).","DOI":"10.1177\/11795549221097675"},{"key":"1086_CR21","doi-asserted-by":"publisher","first-page":"14435","DOI":"10.1038\/s41598-019-50849-y","volume":"9","author":"T Sasaki","year":"2019","unstructured":"Sasaki T, Kinoshita M, Fujita K, et al. Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma. Sci Rep. 2019;9:14435.","journal-title":"Sci Rep"},{"issue":"10","key":"1086_CR22","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.diii.2014.06.013","volume":"95","author":"A Raimbault","year":"2014","unstructured":"Raimbault A, Cazals X, Lauvin MA, Destrieux C, Chapet S, Cottier JP. Radionecrosis of malignant glioma and cerebral metastasis: a diagnostic challenge in MRI. Diagn Interv Imaging. 2014;95(10):985\u20131000.","journal-title":"Diagn Interv Imaging"},{"issue":"6","key":"1086_CR23","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/neuonc\/now256","volume":"19","author":"H Zhou","year":"2017","unstructured":"Zhou H, Vallieres M, Bai HX, Su C, Tang H, Oldridge D, et al. MRI features predict survival and molecular markers in diffuse lower-grade gliomas. Neuro Oncol. 2017;19(6):862\u201370.","journal-title":"Neuro Oncol"},{"issue":"10","key":"1086_CR24","doi-asserted-by":"publisher","first-page":"e24850","DOI":"10.1097\/MD.0000000000024850","volume":"100","author":"H Liu","year":"2021","unstructured":"Liu H, Shen L, Huang X, Zhang G. Maximal tumor diameter in the preoperative tumor magnetic resonance imaging (MRI) T2 image is associated with prognosis of Grade II Glioma. Med (Baltim). 2021;100(10):e24850.","journal-title":"Med (Baltim)"},{"issue":"9","key":"1086_CR25","doi-asserted-by":"publisher","first-page":"e0203639","DOI":"10.1371\/journal.pone.0203639","volume":"13","author":"CR Garcia","year":"2018","unstructured":"Garcia CR, Slone SA, Pittman T, St Clair WH, Lightner DD, Villano JL. Comprehensive evaluation of treatment and outcomes of low-grade diffuse gliomas. PLoS ONE. 2018;13(9):e0203639.","journal-title":"PLoS ONE"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-023-01086-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-023-01086-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-023-01086-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:16:03Z","timestamp":1700388963000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-023-01086-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1186\/s12880-023-01086-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2380943\/v1","asserted-by":"object"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]},"assertion":[{"value":"15 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All the study protocols were conducted in accordance with the ethical guidelines of the Declaration of Helsinki. The study was approved by the Ethics Committee of the First Affiliated Hospital of Soochow University. The need for Informed Consent was waived by the Ethics Committee of the First Affiliated Hospital of Soochow University due to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"116"}}